$BXP

BXP Declares Regular Quarterly Dividend

BXP, Inc. (NYSE: BXP) said its board declared a regular quarterly cash dividend of $0.70 per common share for April 1, 2026 to June 30, 2026. The dividend is payable July 31, 2026 to shareholders of record as of June 30, 2026. The company is a REIT focused on office properties in major U.S. gateway markets.

Original reporting
Published Jun 17, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 17, 2026, 11:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BXP Declares Regular Quarterly Dividend — source image
Decision brief

The 30-second read

$BXPBullishLow
01

Why it matters

The disclosed $0.70/share dividend and key dates may support yield-oriented demand, but the text contains no new fundamentals (no FFO, occupancy, leasing, or guidance).

02

Market read

Primarily a corporate action for income investors; limited trading edge for directional bets without additional financial updates.

03

What to watch

Ex-dividend timing and broader rates/credit conditions may dominate the stock’s reaction more than the declared amount.

Relevance 5/10Novelty 4/10Timing: Dividend payable July 31; record date June 30.

Background

BXP is a REIT developer/owner/manager of office properties, and the article is a dividend declaration notice.

Company-level read

Ticker impact

$BXPBullishHigh confidence
Context

BXP’s board declared a regular quarterly cash dividend of $0.70/share for Apr 1–Jun 30, 2026, payable July 31.

Expected impact

Likely limited near-term impact; any reaction should be small and fade unless paired with other catalysts.

Evidence & confidence

The article discloses only a dividend amount, period, and payment/record dates—no earnings, guidance, or balance-sheet change.

Market effects

Reinforces REIT dividend continuity expectations, but provides no sector-wide new information.

None indicated; portfolio markets are mentioned only as background.

None indicated; dividend is company-specific.

Counterpoint

Dividend declarations can be largely mechanical; traders may discount it if payout ratio or FFO coverage is not discussed.

Key entities

  • BXP, Inc.

    Declared a regular quarterly cash dividend of $0.70 per share for Apr 1–Jun 30, 2026; payable July 31, 2026; record June 30, 2026.

Related articles

$BXPMed

BXP, Inc. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics BXP delivered a strong second quarter, exceeding FFO guidance by $0.08 and raising the 2026 midpoint by $0.05, driven by faster-than-expected leasing and occupancy gains. Management attributes the leasing momentum to a 'very healthy environment' for premier workplaces, noting that AI is acting as a significant tailwind by driving space expansions and upgrades among tech and professional service firms.

$BXPMed

BXP Secures $1.2B Construction Loan for 343 Madison Avenue Office Tower – Commercial Observer

BXP announced it secured a $1.2B construction loan for its 930,000 sq ft, 46-story office tower at 343 Madison Ave in Midtown, with a four-year term plus a one-year extension option, from Wells Fargo, Bank of America Securities, BNY Mellon and J.P. Morgan. Completion is set for 2029; the project is 50% pre-leased. BXP reported Q2 2026 FFO of $283.4M ($1.78/share) and revenue of $895.7M.

$BXPMed

BXP Selling 7 Times Square Ground Lease

Boston Properties (BXP) is marketing the 7 Times Square ground lease via Eastdil Secured, hiring Will Silverman and Gary Phillips. BXP expects proceeds of $700 million to $750 million, with bids due soon. The 1.2M sq ft tower has a 99-year lease and is 91% occupied. The deal would test Times Square office demand.

$BXPMed

Q3 Financial Results 2025-26

Beximco Pharmaceuticals PLC (AIM: BXP) reported unaudited Q3 and nine-month results ended 31 March 2026. For nine months, net sales rose 13.1% to BDT 41,428.0m (£256.9m) and profit after tax increased 34.0% to BDT 7,048.6m (£43.7m). In Q3, net sales grew 8.1% to BDT 13,627.8m (£84.5m) and PAT rose 30.6% to BDT 2,254.4m (£14.0m).